# PuREC Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/purec-co

- Industry: Biotechnology
- Headquarters: Izumo-shi, Japan
- Website: www.purec.jp
- Total disclosed funding: $12M
- Latest round: Series C (Mar 30, 2022)
- Investors on record: 6

## About

Based in Japan, PuREC Co., Ltd. is engaged in the development and commercialization of high-purity mesenchymal stem cells (MSCs), aiming to advance regenerative medicine through their innovative technologies.PuREC Co., Ltd. specializes in the cultivation of high-purity MSCs for therapeutic applications. Founded in 2016 in Izumo-shi, Japan, the company has completed a total of 3 funding deals. Its most recent funding round was the Series C in March 2022, securing JPY 700 million from investors including Gogin Capital, Mochida Pharmaceutical, and San-in Godo Bank. The current CEO is Hide Takahashi.PuREC is focused on developing and commercializing high-purity mesenchymal stem cells under the brand name Rapidly Expanding Cells (REC). Their core offerings include MSCs cultivated through proprietary techniques that maintain essential cell functions, intended for therapeutic use in clinical research institutions and hospitals primarily in Japan and the United States.PuREC generates revenue through the sale of high-purity MSCs and related services tailored for clinical applications. Their B2B model serves hospitals and research institutions that procure MSCs for clinical studies. Additionally, they provide contract services for cell separation and cultivation, diversifying their revenue streams.Following the JPY 700 million raised in the Series C funding round on March 30, 2022, PuREC aims to enhance its product offerings and expand into new geographic markets, particularly targeting regions in Asia and North America by 2024. The funds will be directed towards developing new MSC products and advancing their research capabilities.

## Funding rounds

- Series C, Mar 30, 2022, $5.7M — Mochida Pharmaceutical, Gogin Capital, San-in Godo Bank
- Series B, Jun 19, 2019, $5.3M — Gogin Capital, Fujifilm Holdings Corporation, Fast Track Initiative
- Series A, Jan 26, 2016, $0.7M — Gogin Capital, Fast Track Initiative, Regional Economy Vitalization Corporation of Japan (REVIC)

## Investors

- Gogin Capital — Series A, Series B, Series C
- Fast Track Initiative (https://capitalatlas.ai/funds/fast-track-initiative) — Series A, Series B
- Regional Economy Vitalization Corporation of Japan (REVIC) — Series A
- Fujifilm Holdings Corporation — Series B
- Mochida Pharmaceutical — Series C
- San-in Godo Bank — Series C